Article
Molecular and Clinical Characteristics of Patients with Non-Small Cell Lung Cancer Harboring KRAS G12V Mutations.
Clinical cancer research : an official journal of the American Association for Cancer Research - 15 May 2026
John Felix, Ruge Lea, Verheyen Malte, Scharpenseel Heather, Michels Sebastian Yves Friedrich, Riedel Richard, Fischer Rieke, Jakob Carolin, Siemanowski-Hrach Janna, Fassunke Jana, Heydt Carina, Ihle Michaela Angelika, Lyu Su Ir, Rasokat Anna, Schulte Wolfgang, Franke Karl-Josef, Graeven Ullrich, Kappes Jutta, Kron Anna, Siebolts Udo, Merkelbach-Bruse Sabine, Quaas Alexander, Büttner Reinhard, Wolf Jürgen, Scheffler Matthias
Abstract excerpt
PURPOSE: KRAS G12V is among the most frequent KRAS mutations in non-small cell lung cancer (NSCLC), yet its clinical and molecular features remain poorly understood. EXPERIMENTAL DESIGN: In this retrospective study, we analyzed 636 patients with KRAS G12V-mutated NSCLC diagnosed between 2018 and 2023. Clinical, pathologic, and molecular characteristics, including co-mutations, smoking history, programmed cell...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
